Scinovex
article Open AccessTop 1% cited

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Annals of the Rheumatic Diseases · 2020 · Vol. 79(6) · pp. 685–699
Josef S SmolenRobert LandewéJ. W. J. BijlsmaGerd R BurmesterMaxime DougadosAndreas KerschbaumerIain B. McInnesAlexandre SeprianoRonald van VollenhovenMaarten de WitDaniel AletahaMartin AringerJohan AsklingAlejandro BalsaMaarten BoersAlfons A den BroederMaya H BuchFrank ButtgereitRoberto CaporaliMyrna CardielDiederik De CockCătălin CodreanuMaurizio CutoloChristopher J EdwardsYvonne van Eijk‐HustingsPaul EmeryAxel FinckhLaure GossecJacques‐Eric GottenbergMerete Lund HetlandT. HuizingaMarios KoloumasZhanguo LiXavier MarietteUlf Müller‐LadnerEduardo MyslerJosé António Pereira da SilvaGyula PoórJanet PopeAndrea Rubbert‐RothAdeline Ruyssen‐WitrandKenneth G. SaagAnja StrangfeldTsutomu TakeuchiMarieke VoshaarRené WesthovensDésirée van der Heijde
Rheumatoid Arthritis Research and TherapiesBiosimilars and Bioanalytical MethodsSystemic Lupus Erythematosus ResearchMedicineAntirheumatic drugsRheumatoid arthritisAntirheumatic AgentsDisease managementIntensive care medicineArthritisDiseaseBiological drugsPhysical therapy

Funding

  • European League Against Rheumatism
Citations
2,709
FWCI
366.22
field-weighted impact
References
123
Percentile
100%
vs. same field & year
Citations per year
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update · Scinovex